CB-5339 - CASI
Folotyn (pralatrexate) - Aurobindo
BI-1206 - BioInvent
captisol-enabled melphalan - Generic mfg.
CID-103 - CASI, Precision Autoimmune Therap
Yuanruida (inaticabtagene autoleucel) - CASI
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/casi-pharmaceuticals-enters-into-definitive-agreement-for-the-divesti-1026311
 
May 12, 2025
 
Next